Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001599298-22-000147
Filing Date
2022-12-21
Accepted
2022-12-21 16:20:10
Documents
99
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A smmt-20211231.htm   iXBRL 10-K/A 1212733
2 EX-23.1 sum-ex231_20211231x10xkaxu.htm EX-23.1 2304
3 EX-23.2 sum-ex232_20211231x10xkaxu.htm EX-23.2 2354
4 EX-31.1 sum-ex311_20211231x10xka.htm EX-31.1 11766
5 EX-31.2 sum-ex312_20211231x10xka.htm EX-31.2 11791
6 EX-31.3 sum-ex313_20211231x10xka.htm EX-31.3 11745
7 EX-32.1 sum-ex321_20211231x10xka.htm EX-32.1 11053
  Complete submission text file 0001599298-22-000147.txt   7676003

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20211231.xsd EX-101.SCH 61638
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20211231_cal.xml EX-101.CAL 82949
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20211231_def.xml EX-101.DEF 257384
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20211231_lab.xml EX-101.LAB 724092
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20211231_pre.xml EX-101.PRE 507240
93 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20211231_htm.xml XML 1168125
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36866 | Film No.: 221478672
SIC: 2834 Pharmaceutical Preparations